Valuation Oragenics, Inc.

Stocks

Market Closed - NYSE 00:00:00 02/10/2026 +04			5-day change	1st Jan Change
0.4800 ^USD	-2.40%		-4.57%	-38.71%

08-14	Oragenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-07	Oragenics Achieves Full Activation of Australian Phase IIa Trial Network for ONP-002 and Advances U.S. Regulatory Pathway	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	41.2	51.91	12.36	14.46	4.51	3.265
Change	-	25.99%	-76.19%	16.96%	-68.8%	-27.62%
Enterprise Value (EV) ¹	24.46	25.44	1.557	11.3	3.974	-4.908
Change	-	4.01%	-93.88%	625.27%	-64.82%	-223.5%
P/E	-0.96x	-3.21x	-0.89x	-0.61x	-0.23x	-0.17x
PBR	4.26x	2.18x	1.12x	11x	-21.9x	0.4x
PEG	-	0x	0.1x	-0x	0x	0x
Capitalization / Revenue	-	596,776,875x	93,974,407x	383,927,682x	-	-
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-0.92x	-1.62x	-0.11x	-0.54x	-0.38x	-
EV / EBIT	-0.92x	-1.61x	-0.11x	-0.54x	-0.38x	0.52x
EV / FCF	-1.58x	-3.08x	-0.15x	-1.22x	-0.62x	0.85x
FCF Yield	-63.3%	-32.5%	-681%	-81.7%	-162%	117%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-841.7	-250.5	-213.4	-275.5	-47.88	-4.563
Distribution rate	-	-	-	-	-	-
Net sales	-	0.087	0.1315	0.0377	-	-
EBITDA ¹	-26.59	-15.73	-14.38	-20.88	-10.53	-
EBIT ¹	-26.64	-15.77	-14.42	-20.9	-10.56	-9.363
Net income ¹	-26.43	-15.71	-14.29	-20.66	-10.57	-9.842
Net Debt ¹	-16.74	-26.47	-10.8	-3.161	-0.5363	-8.172
Reference price ²	808.2808	802.8803	189.1989	168.8059	11.0801	0.7832
Nbr of stocks (in thousands)	51	64.7	65.3	85.6	407	4,168
Announcement Date	01/03/21	24/03/22	17/04/23	29/03/24	14/03/25	16/03/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ORAGENICS, INC.	-	-	-	-	2.22M
WUXI APPTEC CO., LTD.	21.73x	7.77x	15.61x	1.37%	74.46B
ARGENX SE	31.25x	9.01x	28.06x	0.04%	60.14B
LONZA GROUP AG	33.64x	6.03x	18.07x	0.97%	48.15B
IQVIA HOLDINGS INC.	34.63x	3.34x	14.4x	-.--%	44.25B
REVOLUTION MEDICINES, INC.	-21.16x	229.18x	-22.81x	-.--%	43.99B
BEONE MEDICINES AG	47.94x	5.54x	30.43x	-.--%	41.61B
CELLTRION, INC.	26.89x	7.76x	19.96x	0.42%	29.97B
WUXI BIOLOGICS (CAYMAN) INC.	33.91x	7.26x	18.84x	-.--%	29.31B
INSMED INCORPORATED	-70.02x	13.44x	-68.51x	-.--%	24.93B
Average	15.42x	32.15x	6.01x	0.31%	39.68B
Weighted average by Cap.	19.58x	31.88x	10.24x	0.41%